Corynebacterium
Corynebacterium
Corynebacterium
Corynebacterium
Corynebacterium ulcerans colonies on
a blood agar plate
Scientific classification
Domai Bacteria
n:
Phylum Actinomycetota
:
Class: Actinomycetia
Order: Mycobacteriales
Family: Corynebacteriaceae
Lehmann and Neumann 1907
Genus: Corynebacterium
Lehmann and Neumann 1896
Corynebacterium diphtheriae
Species
See text.
Synonyms
Bacterionema Gilmou
r et al. 1961 (Approved
Lists 1980)
Caseobacter Crombac
h 1978 (Approved Lists
1980)
Turicella Funke et al.
1994
Contents
1Taxonomy
2Genomics
3Characteristics
o 3.1Cell wall
o 3.2Culture
4Habitat
5Role in disease
6Industrial uses
7Species
8References
9Further reading
Taxonomy[edit]
The genus Corynebacterium was created by Lehmann and Neumann in 1896 as
a taxonomic group to contain the bacterial rods responsible for causing diphtheria. The
genus was defined based on morphological characteristics. Based on studies of 16S-
rRNA, they have been grouped into the subdivision of Gram-positive Eubacteria with
high G:C content, with close phylogenetic relationship
to Arthrobacter, Mycobacterium, Nocardia, and Streptomyces.[6]
The term comes from Greek κορύνη, korýnē 'club, mace, staff, knobby plant bud or
shoot'[7] and βακτήριον, baktḗrion 'little rod'.[8] The term "diphtheroids" is used to
represent corynebacteria that are nonpathogenic; for example, C. diphtheriae would be
excluded.[citation needed] The term diphtheroid comes from Greek διφθέρα, diphthérā 'prepared
hide, leather'.[9][10]
Genomics[edit]
Comparative analysis of corynebacterial genomes has led to the identification of
several conserved signature indels (CSIs) that are unique to the genus. Two examples
of CSIs are a two-amino-acid insertion in a conserved region of the enzyme
phosphoribose diphosphate:decaprenyl-phosphate phosphoribosyltransferase and a
three-amino-acid insertion in acetate kinase, both of which are found only
in Corynebacterium species. Both of these indels serve as molecular markers for
species of the genus Corynebacterium. Additionally, 16 conserved signature proteins,
which are uniquely found in Corynebacterium species, have been identified. Three of
these have homologs found in the genus Dietzia, which is believed to be the closest
related genus to Corynebacterium. In phylogenetic trees based on concatenated protein
sequences or 16S rRNA, the genus Corynebacterium forms a distinct clade, within
which is a distinct subclade, cluster I. The cluster is made up of the species C.
diphtheriae, C. pseudotuberculosis, C. ulcerans, C. aurimucosum, C.
glutamicum, and C. efficiens. This cluster is distinguished by several conserved
signature indels, such as a two-amino-acid insertion in LepA and a seven- or eight-
amino-acid insertions in RpoC. Also, 21 conserved signature proteins are found only in
members of cluster I. Another cluster has been proposed, consisting of C.
jeikeium and C. urealyticum, which is supported by the presence of 19 distinct
conserved signature proteins which are unique to these two species. [11] Corynebateria
have a high G+C content ranging from 46-74 mol%.[12]
Characteristics[edit]
The principal features of the genus Corynebacterium were described by Collins and
Cummins in 1986.[13] They are gram-positive, catalase-positive, non-spore-forming, non-
motile, rod-shaped bacteria that are straight or slightly curved. [14] Metachromatic
granules are usually present representing stored phosphate regions. Their size falls
between 2 and 6 μm in length and 0.5 μm in diameter. The bacteria group together in a
characteristic way, which has been described as the form of a "V", "palisades", or
"Chinese characters". They may also appear elliptical. They are aerobic or facultatively
anaerobic, chemoorganotrophs. They are pleomorphic through their lifecycles, they
occur in various lengths, and they frequently have thickenings at either end, depending
on the surrounding conditions.[15]
Some corynebacteria are lipophilic (such as CDC coryneform groups F-1 and G, C.
accolens, C. afermentans subsp. lipophilum, C. bovis,[16] C. jeikeium, C. macginleyi, C.
uropygiale,[17] and C. urealyticum), but most are not.[citation needed] The nonlipophilic bacteria
may be classified as fermentative (such as C. amycolatum; C. argentoratense,
members of the C. diphtheriae group, C. glucuronolyticum, C. glutamicum, C.
matruchotii, C. minutissimum, C. striatum, and C. xerosis) or nonfermentative (such
as C. afermentans subsp. afermentans, C. auris, C. pseudodiphtheriticum, and C.
propinquum).[16]
Cell wall[edit]
The cell wall is distinctive, with a predominance of mesodiaminopimelic acid in
the murein wall[3][14] and many repetitions of arabinogalactan, as well as corynemycolic
acid (a mycolic acid with 22 to 26 carbon atoms), bound by disaccharide bonds called L-
Rhap-(1 → 4)--D-GlcNAc-phosphate. These form a complex commonly seen
in Corynebacterium species: the mycolyl-AG–peptidoglican (mAGP). [18] Unlike most
corynebacteria, Corynebacterium kroppenstedtii does not contain mycolic acids.[19]
Culture[edit]
Corynebacteria grow slowly, even on enriched media. In nutritional requirements, all
need biotin to grow. Some strains also need thiamine and PABA.[13] Some of
the Corynebacterium species with sequenced genomes have between 2.5 and 3.0
million base pairs. The bacteria grow in Loeffler's medium, blood agar, and trypticase
soy agar (TSA). They form small, grayish colonies with a granular appearance, mostly
translucent, but with opaque centers, convex, with continuous borders. [14] The color
tends to be yellowish-white in Loeffler's medium. In TSA, they can form grey colonies
with black centers and dentated borders that either resemble flowers (C. gravis),
continuous borders (C. mitis), or a mix between the two forms (C. intermedium).
Habitat[edit]
Corynebacterium species occur commonly in nature in soil, water, plants, and food
products.[3][14] The nondiphtheiroid Corynebacterium species can even be found in
the mucosa and normal skin flora of humans and animals.[3][14] Unusual habitats, such as
the preen gland of birds have been recently reported for Corynebacterium uropygiale.
Some species are known for their pathogenic effects in humans and other animals.
[17]
Perhaps the most notable one is C. diphtheriae, which acquires the capacity to
produce diphtheria toxin only after interacting with a bacteriophage.[20][21] Other
pathogenic species in humans include: C. amycolatum, C. striatum, C. jeikeium, C.
urealyticum, and C. xerosis;[22][23][24][25][26] all of these are important as pathogens
in immunosuppressed patients. Pathogenic species in other animals include C.
bovis and C. renale.[27] This genus has been found to be part of the human salivary
microbiome.[28]
Role in disease[edit]
Main article: Diphtheria
The most notable human infection is diphtheria, caused by C. diphtheriae. It is an acute,
contagious infection characterized by pseudomembranes of dead epithelial cells, white
blood cells, red blood cells, and fibrin that form around the tonsils and back of the
throat.[29] In developed countries, it is an uncommon illness that tends to occur in
unvaccinated individuals, especially school-aged
children, elderly, neutropenic or immunocompromised patients, and those with
prosthetic devices such as prosthetic heart valves, shunts, or catheters. It is more
common in developing countries[30] It can occasionally infect wounds, the vulva,
the conjunctiva, and the middle ear. It can be spread within a hospital.[31] The virulent
and toxigenic strains produce an exotoxin formed by two polypeptide chains, which is
itself produced when a bacterium is transformed by a gene from the β prophage.[20][21]
Several species cause disease in animals, most notably C. pseudotuberculosis, which
causes the disease caseous lymphadenitis, and some are also pathogenic in humans.
Some attack healthy hosts, while others tend to attack the immunocompromised.
Effects of infection include granulomatous lymphadenopathy, pneumonitis, pharyngitis,
skin infections, and endocarditis. Corynebacterial endocarditis is seen most frequently
in patients with intravascular devices.[32] Several species of Corynebacterium can
cause trichomycosis axillaris.[33] C. striatum may cause axillary odor.[34] C.
minutissimum causes erythrasma.
Industrial uses[edit]
Nonpathogenic species of Corynebacterium are used for important industrial
applications, such as the production of amino acids[35] and nucleotides, bioconversion
of steroids,[36] degradation of hydrocarbons,[37] cheese aging,[38] and production
of enzymes.[39] Some species produce metabolites similar to antibiotics: bacteriocins of
the corynecin-linocin type,[31][40][41] antitumor agents,[42] etc. One of the most studied species
is C. glutamicum, whose name refers to its capacity to produce glutamic acid in aerobic
conditions.[43]
L-Lysine production is specific to C. glutamicum in which core metabolic enzymes are
manipulated through genetic engineering to drive metabolic flux towards the production
of NADPH from the pentose phosphate pathway, and L-4-aspartyl phosphate, the
commitment step to the synthesis of L-lysine, lysC, dapA, dapC, and dapF. These
enzymes are up-regulated in industry through genetic engineering to ensure adequate
amounts of lysine precursors are produced to increase metabolic flux. Unwanted side
reactions such as threonine and asparagine production can occur if a buildup of
intermediates occurs, so scientists have developed mutant strains of C.
glutamicum through PCR engineering and chemical knockouts to ensure production of
side-reaction enzymes are limited. Many genetic manipulations conducted in industry
are by traditional cross-over methods or inhibition of transcriptional activators. [44]
Expression of functionally active human epidermal growth factor has been brought
about in C. glutamicum,[45] thus demonstrating a potential for industrial-scale production
of human proteins. Expressed proteins can be targeted for secretion through either the
general secretory pathway or the twin-arginine translocation pathway.[46]
Unlike gram-negative bacteria, the gram-positive Corynebacterium species
lack lipopolysaccharides that function as antigenic endotoxins in humans.[citation needed]
Species[edit]
Corynebacterium comprises the following species:[47]
References[edit]
1. ^ Lehmann KB, Neumann R. (1896). Atlas und Grundriss der Bakteriologie und Lehrbuch der
speziellen bakteriologischen Diagnostik [Atlas and outline of bacteriology and textbook of
special bacteriological diagnostics] (1st ed.). München: J.F. Lehmann.
2. ^ Lehmann KB, Neumann R. (1907). Lehmann's Medizin, Handatlanten X. Atlas und
Grundriss der Bakteriologie und Lehrbuch der speziellen bakteriologischen
Diagnostik [Lehmann's Medicine, Handbook X. Atlas and outline of bacteriology and textbook
of special bacteriological diagnostics] (4th ed.). Munchen: J. F. Lehmann.
3. ^ Jump up to:a b c d Collins, M. D. (2004). "Corynebacterium caspium sp. nov., from a Caspian
seal (Phoca caspica)". International Journal of Systematic and Evolutionary
Microbiology. 54 (3): 925–8. doi:10.1099/ijs.0.02950-0. PMID 15143043.
4. ^ Poetsch, A. (2011). "Proteomics of corynebacteria: From biotechnology workhorses to
pathogens". Proteomics. 11 (15): 3244–
3255. doi:10.1002/pmic.201000786. PMID 21674800. S2CID 44274690.
5. ^ Burkovski A., ed. (2008). Corynebacteria: Genomics and Molecular Biology. Caister
Academic Press. ISBN 978-1-904455-30-1.[page needed]
6. ^ Woese, C. R. (1987). "Bacterial evolution". Microbiological Reviews. 51 (2): 221–
71. doi:10.1128/MMBR.51.2.221-271.1987. PMC 373105. PMID 2439888.
7. ^ κορύνη. Liddell, Henry George; Scott, Robert; A Greek–English Lexicon at the Perseus
Project.
8. ^ βακτήριον, βακτηρία in Liddell and Scott.
9. ^ διφθέρα in Liddell and Scott.
10. ^ Harper, Douglas. "diphtheria". Online Etymology Dictionary.
11. ^ Gao, B.; Gupta, R. S. (2012). "Phylogenetic Framework and Molecular Signatures for the
Main Clades of the Phylum Actinobacteria". Microbiology and Molecular Biology
Reviews. 76 (1): 66–112. doi:10.1128/MMBR.05011-11. PMC 3294427. PMID 22390973.
12. ^ Bernard, K.A.; Funke, G. (2012). "Genus I. Corynebacterium". In Goodfellow, M.; Kampfer,
P.; Busse, H.J.; Trujillo, M.E.; Suzuki, K.; Ludwig, W.; Whitman, W.B. (eds.). Bergey's
Manual of Systematic Bacteriology (2nd ed.). Springer. p. 245.
13. ^ Jump up to:a b Collins, M. D.; Cummins, C. S. (1986). "Genus Corynebacterium Lehmann
and Neumann 1896, 350AL". In Sneath, P. H. A.; Mair, N. S.; Sharpe, M. E.; Holt, J. G.
(eds.). Bergey's Manual of Systematic Bacteriology. Vol. 2. Baltimore: Williams & Wilkins.
pp. 1266–76.
14. ^ Jump up to:a b c d e Yassin, A. F. (2003). "Corynebacterium glaucum sp. nov". International
Journal of Systematic and Evolutionary Microbiology. 53 (3): 705–9. doi:10.1099/ijs.0.02394-
0. PMID 12807190.
15. ^ Keddie, R. M.; Cure, G. L. (1977). "The Cell Wall Composition and Distribution of Free
Mycolic Acids in Named Strains of Coryneform Bacteria and in Isolates from Various Natural
Sources". Journal of Applied Bacteriology. 42 (2): 229–52. doi:10.1111/j.1365-
2672.1977.tb00689.x. PMID 406255.
16. ^ Jump up to:a b Funke, G; von Graevenitz, A; Clarridge Je, 3rd; Bernard, K. A.
(1997). "Clinical microbiology of coryneform bacteria". Clinical Microbiology Reviews. 10 (1):
125–59. doi:10.1128/CMR.10.1.125. PMC 172946. PMID 8993861.
17. ^ Jump up to:a b Braun, Markus Santhosh; Zimmermann, Stefan; Danner, Maria; Rashid,
Harun-or; Wink, Michael (2016). "Corynebacterium uropygiale sp. nov., isolated from the
preen gland of turkeys (Meleagris gallopavo)". Systematic and Applied Microbiology. 39 (2):
88–92. doi:10.1016/j.syapm.2015.12.001. PMID 26776107.
18. ^ Seidel, M.; Alderwick, L. J.; Sahm, H.; Besra, G. S.; Eggeling, L. (2006). "Topology and
mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium
glutamicum as a model of Emb proteins of Mycobacterium
tuberculosis". Glycobiology. 17 (2): 210–9. doi:10.1093/glycob/cwl066. PMID 17088267.
19. ^ Collins, M. D.; Falsen, E.; Akervall, E.; et al. (1998). "Note: Corynebacterium
kroppenstedtii sp. nov., a novel corynebacterium that does not contain mycolic
acids". International Journal of Systematic Bacteriology. 48 (4): 1449–
54. doi:10.1099/00207713-48-4-1449. PMID 9828448.
20. ^ Jump up to:a b Costa, J. J.; Michel, J. L.; Rappuoli, R; Murphy, J. R. (1981). "Restriction map
of corynebacteriophages beta c and beta vir and physical localization of the diphtheria tox
operon". Journal of Bacteriology. 148 (1): 124–30. doi:10.1128/JB.148.1.124-
130.1981. PMC 216174. PMID 6270058.
21. ^ Jump up to:a b SIB: Viral exotoxin. Expasy: ViralZone. Accessed 2 Feb 2021
22. ^ Oteo, Jesús; Aracil, Belén; Ignacio Alós, Juan; Luis Gómez-Garcés, Jose (2001).
"Bacteriemias significativas por Corynebacterium amycolatum: Un patógeno emergente"
[Significant bacteremias by Corynebacterium amycolatum: an emergent
pathogen]. Enfermedades Infecciosas y Microbiología Clínica (in Spanish). 19 (3): 103–
6. doi:10.1016/S0213-005X(01)72578-5. PMID 11333587.
23. ^ Lagrou, K; Verhaegen, J; Janssens, M; Wauters, G; Verbist, L (1998). "Prospective Study of
Catalase-positive Coryneform Organisms in Clinical Specimens: Identification, Clinical
Relevance, and Antibiotic Susceptibility". Diagnostic Microbiology and Infectious
Disease. 30 (1): 7–15. doi:10.1016/S0732-8893(97)00193-4. PMID 9488824.
24. ^ Boc, SF; Martone, JD (1995). "Osteomyelitis caused by Corynebacterium jeikeium". Journal
of the American Podiatric Medical Association. 85 (6): 338–9. doi:10.7547/87507315-85-6-
338. PMID 7602508.
25. ^ Kono, M.; Sasatsu, M.; Aoki, T. (1983). "R Plasmids in Corynebacterium xerosis
Strains". Antimicrobial Agents and Chemotherapy. 23 (3): 506–
8. doi:10.1128/aac.23.3.506. PMC 184682. PMID 6847177.
26. ^ Pitcher, D.G. (1983). "Deoxyribonucleic acid base composition
of Corynebacterium diphtheriaeand other corynebacteria with cell wall type IV" . FEMS
Microbiology Letters. 16 (2–3): 291–5. doi:10.1111/j.1574-6968.1983.tb00305.x.
27. ^ Hirsbrunner, G; Lang, J; Nicolet, J; Steiner, A (1996). "Nephrektomie nach chronischer,
unilateraler, eitriger Pyelonephritis beim Rind" [Nephrectomy for chronic, unilateral
suppurative pyleonephritis in cattle]. Tierarztliche Praxis (in German). 24 (1): 17–
21. PMID 8720950.
28. ^ Wang, Kun; Lu, Wenxin; Tu, Qichao; et al. (10 March 2016). "Preliminary analysis of
salivary microbiome and their potential roles in oral lichen planus". Scientific Reports. 6 (1):
22943. Bibcode:2016NatSR...622943W. doi:10.1038/srep22943. PMC 4785528. PMID 269
61389.
29. ^ "Difteria: MedlinePlus enciclopedia médica". www.nlm.nih.gov.
30. ^ Iizuka, Hideyo; Furuta, Joana Akiko; Oliveira, Edison P. Tavares de (1980). "Difteria:
Situação imunitária de uma população infantil urbana de São Paulo, SP, Brasil" [Diphtheria.
Immunity in an infant population in the City of S. Paulo, SP, Brazil]. Revista de Saúde
Pública (in Portuguese). 14 (4): 462–8. doi:10.1590/S0034-
89101980000400005. PMID 7268290.
31. ^ Jump up to:a b Kerry-Williams, S. M.; Noble, W. C. (2009). "Plasmids in group JK coryneform
bacteria isolated in a single hospital". Journal of Hygiene. 97 (2): 255–
63. doi:10.1017/S0022172400065347. PMC 2083551. PMID 3023480.
32. ^ León, Cristóbal; Ariza, Javier (2004). "Guías para el tratamiento de las infecciones
relacionadas con catéteres intravasculares de corta permanencia en adultos: Conferencia de
consenso SEIMC-SEMICYUC" [Guidelines for the treatment of infections related to short-stay
intravascular catheters in adults: consensus conference SEIMC-SEMICYUC]. Enfermedades
Infecciosas y Microbiología Clínica (in Spanish). 22 (2): 92–7. doi:10.1016/S0213-
005X(04)73041-4. PMID 14756991.
33. ^ Trichomycosis axillaris at eMedicine
34. ^ Natsch, A.; Gfeller, H.; Gygax, P.; Schmid, J. (2005). "Isolation of a bacterial enzyme
releasing axillary malodor and its use as a screening target for novel deodorant
formulations1". International Journal of Cosmetic Science. 27 (2): 115–
22. doi:10.1111/j.1467-2494.2004.00255.x. PMID 18492161. S2CID 22554216.
35. ^ Yamada, K.; Kinoshita, S.; Tsunoda, T.; Aida, K., eds. (1972). The Microbial Production of
Amino Acids. New York: Wiley.
36. ^ Constantinides, Alkis (1980). "Steroid transformation at high substrate concentrations using
immobilized Corynebacterium simplex cells". Biotechnology and Bioengineering. 22 (1):
119–36. doi:10.1002/bit.260220110. PMID 7350926. S2CID 29703826.
37. ^ Cooper, D. G.; Zajic, J. E.; Gracey, D. E. (1979). "Analysis of corynomycolic acids and other
fatty acids produced by Corynebacterium lepus grown on kerosene". Journal of
Bacteriology. 137 (2): 795–801. doi:10.1128/JB.137.2.795-
801.1979. PMC 218359. PMID 422512.
38. ^ Lee, Chang-Won; Lucas, Serge; Desmazeaud, Michel J. (1985). "Phenylalanine and
tyrosine catabolism in some cheese coryneform bacteria". FEMS Microbiology
Letters. 26 (2): 201–5. doi:10.1111/j.1574-6968.1985.tb01591.x.
39. ^ Khurana, Sumit; Sanli, Gulsah; Powers, David B.; et al. (2000). "Molecular modeling of
substrate binding in wild-type and mutant Corynebacteria 2,5-diketo-D-gluconate
reductases". Proteins: Structure, Function, and Genetics. 39 (1): 68–
75. CiteSeerX 10.1.1.661.3412. doi:10.1002/(SICI)1097-0134(20000401)39:1<68::AID-
PROT7>3.0.CO;2-Y. PMID 10737928. S2CID 24526523.
40. ^ Kerry-Williams, S.M.; Noble, W.C. (1984). "Plasmid-associated bacteriocin production in a
JK-type coryneform bacterium". FEMS Microbiology Letters. 25 (2–3): 179–
82. doi:10.1111/j.1574-6968.1984.tb01451.x.
41. ^ Suzuki, Takeo; Honda, Haruo; Katsumata, Ryoichi (1972). "Production of Antibacterial
Compounds Analogous to Chloramphenicol by a n-Paraffin-grown Bacterium". Agricultural
and Biological Chemistry. 36 (12): 2223–8. doi:10.1271/bbb1961.36.2223.
42. ^ Milas, Luka; Scott, Martin T. (1978). "Antitumor Activity of Corynebacterium Parvum". In
Ford, Marvella E.; Watson, Dennis K. (eds.). Cancer Disparities. Advances in Cancer
Research. Vol. 26 (1st ed.). pp. 257–306. doi:10.1016/S0065-230X(08)60090-1. ISBN 978-
0-12-809878-3. PMID 343523.
43. ^ Abe, Shigeo; Takayama, KEN-Ichiro; Kinoshita, Shukuo (1967). "Taxonomical Studies on
Glutamic Acid-Producing Bacteria". The Journal of General and Applied Microbiology. 13 (3):
279–301. doi:10.2323/jgam.13.279.
44. ^ Kjeldsen, Kjeld Raunkjær (2009). Optimization of an industrial L-lysine producing
Corynebacterium glutamicum strain (PhD Thesis). Technical University of
Denmark. OCLC 826400572.[page needed]
45. ^ Date, M.; Itaya, H.; Matsui, H.; Kikuchi, Y. (2006). "Secretion of human epidermal growth
factor by Corynebacterium glutamicum". Letters in Applied Microbiology. 42 (1): 66–
70. doi:10.1111/j.1472-765X.2005.01802.x. PMID 16411922. S2CID 20867427.
46. ^ Meissner, Daniel; Vollstedt, Angela; Van Dijl, Jan Maarten; Freudl, Roland (2007).
"Comparative analysis of twin-arginine (Tat)-dependent protein secretion of a heterologous
model protein (GFP) in three different Gram-positive bacteria". Applied Microbiology and
Biotechnology. 76 (3): 633–42. doi:10.1007/s00253-007-0934-
8. PMID 17453196. S2CID 6238466.
47. ^ Euzéby JP, Parte AC. "Corynebacterium". List of Prokaryotic names with Standing in
Nomenclature (LPSN). Retrieved June 21, 2022.
Further reading[edit]
Burkovski, Andreas, ed. (2008). Corynebacteria: Genomics and Molecular
Biology. Caister Academic Press. ISBN 978-1-904455-30-1.
Ryan KJ, Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.).
McGraw Hill. ISBN 978-0-8385-8529-0.
Database of Corynebacterial Transcription Factors and Regulatory Networks
Rollins, David M. University of Maryland: Pathogentic Microbiology:
Corynebacterium [1]
Khamis, A.; Raoult, D.; Scola, B. La (2004). "rpoB gene sequencing for
identification of Corynebacterium species". Journal of Clinical
Microbiology. 42 (9): 3925–3931. doi:10.1128/jcm.42.9.3925-
3931.2004. PMC 516356. PMID 15364970.
Poetsch, A.; Haußmann, U.; Burkovski, A. (2011). "Proteomics of
corynebacteria: From biotechnology workhorses to
pathogens". Proteomics. 2011 (11): 3244–
3255. doi:10.1002/pmic.201000786. PMID 21674800. S2CID 44274690.
Goldenberger, D.; et al. (2014). "Extended characterization of
Corynebacterium pyruviciproducens based on clinical strains from Canada
and Switzerland". Journal of Clinical Microbiology. 52 (9): 3180–
3183. doi:10.1128/jcm.00792-14. PMC 4313134. PMID 24951802.
Hacker, E.; et al. (2015). "Colonization of human epithelial cell lines by
Corynebacterium ulcerans from human and animal
sources". Microbiology. 161 (8): 1582–
1591. doi:10.1099/mic.0.000121. PMID 26066797.
Bernard, K. A.; Munro, C.; Wiebe, D.; Ongsanso, E. (2002). "Characteristics
of rare or recently described Corynebacterium species recovered from
human clinical material in Canada". Journal of Clinical Microbiology. 40 (11):
4375–4381. doi:10.1128/jcm.40.11.4375-4381.2002. PMC 139690. PMID 12
409436.
Bittel, M.; Gastiger, S.; Amin, B.; Hofmann, J.; Burkovski, A. (2018). "Surface
and Extracellular Proteome of the Emerging Pathogen Corynebacterium
ulcerans". Proteomes. 6 (2):
18. doi:10.3390/proteomes6020018. PMC 6027474. PMID 29673200.
Ventura, M.; et al. (2007). "Genomics of Actinobacteria: Tracing the
Evolutionary History of an Ancient Phylum". Microbiology and Molecular
Biology Reviews. 71 (3): 495–548. doi:10.1128/mmbr.00005-
07. PMC 2168647. PMID 17804669.
Hansmeier, N.; Chao, T. C.; Kalinowski, J.; et al. (2006). "Mapping and
comprehensive analysis of the extracellular and cell surface proteome of the
human pathogen Corynebacterium diphtheriae". Proteomics. 2006 (6):
2465–2476. doi:10.1002/pmic.200500360. PMID 16544277. S2CID 227459
61.
Riegel, P.; Ruimy, R.; Christen, R.; Monteil, H. (1996). "Species identities and
antimicrobial susceptibilities of Corynebacteria isolated from various clinical
sources". European Journal of Clinical Microbiology and Infectious
Diseases. 15 (8): 657–
662. doi:10.1007/bf01691153. PMID 8894575. S2CID 9243014.
Carfora, V.; et al. (2018). "Non-toxigenic Corynebacterium ulcerans
sequence types 325 and 339 isolated from two dogs with ulcerative lesions in
Italy. [Internet]". Journal of Veterinary Diagnostic Investigation. 30 (3): 447–
450. doi:10.1177/1040638718764786. PMC 6505817. PMID 29528813.
Nishio, Y.; et al. (2007). "Evolutionary process of amino acid biosynthesis in
Corynebacterium at the whole genome level. [Internet]". Molecular Biology
and Evolution. 21 (9): 1683–
1691. doi:10.1093/molbev/msh175. PMID 15163767.